The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockers
Open accessAbstract
The development of metastases is a decisive step in the course of a cancer disease. The detection of metastases in cancer patients is correlated with a poor prognosis, and over 90% of all deaths from cancer are not due to the primary tumor, which often can be successfully treated, but are due to the metastases. Tumor cell migration, a prerequisite for metastasis development, is not merely genetically determined, but is distinctly regulated by signal substances of the environment including chemokines and neurotransmitters. We have shown previously that the migration of breast, prostate, and colon carcinoma cells is enhanced by the stress‐related neurotransmitter norepinephrine in vitro, and that this effect can be inhibited by the β‐blocker propranolol. We now provide for the first time evidence for the in vivo relevance of this neurotransmitter‐driven regulation using PC‐3 prostate carcinoma cells. The development of lumbar lymph node metastases in athymic BALB/c nude mice increased with the application of norepinephrine via microosmotic pumps, while propranolol inhibited this effect. However, the growth of the primary tumor was not affected by either treatment. Additionally, experiments using human tissue microarrays showed that 70–90 percent of breast, colon, and prostate carcinoma tissues express the relevant β2‐adrenoceptor. Thus, our work contributes to the understanding of the basic cellular mechanisms of metastasis development, and furthermore delivers a rationale for the chemopreventive use of clinically established β‐blockers for the inhibition of metastases. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
Metastasis genes: A progression puzzle
Bernards, R., & Weinberg, R. A. (2002) · Nature · doi:10.1038/418823a · Cited by 798
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
Miyaki, M., Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202642 · Cited by 436
Gene expression profiles of primary breast tumors maintained in distant metastases
Weigelt, B., Glas, A. M., Wessels, L. F. A., Witteveen, A. T., Peterse, J. L., & van't Veer, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634067100 · Cited by 431
Visualizing the kinetics of tumor-cell clearance in living animals
Sweeney, T. J., Mailänder, V., Tucker, A. A., Olomu, A. B., Zhang, W., Cao, Y.-A., Negrin, R. S., & Contag, C. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12044 · Cited by 350
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters
Entschladen, F., Drell, T. L., Lang, K., Joseph, J., & Zaenker, K. S. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01431-7 · Cited by 334
Self-citationNorepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers.
Masur, K., Niggemann, B., Zänker, K. S., & Entschladen, F. (2001) · PubMed · Cited by 308
Self-citationDrell, T. L., Joseph, J., Lang, K., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024491219366 · Cited by 277
Self-citationLang, K., Drell, T. L., Lindecke, A., Niggemann, B., Kaltschmidt, C., Zaenker, K. S., & Entschladen, F. (2004) · International Journal of Cancer · doi:10.1002/ijc.20410 · Cited by 256
Self-citationShakhar, G., & Ben‐Eliyahu, S. (1998) · PubMed · Cited by 253
Shakhar, G., & Ben-Eliyahu, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3251 · Cited by 231
Antihypertensive Drug Use and The Risk of Prostate Cancer (Canada)
Perron, L., Bairati, I., Harel, F., & Meyer, F. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000036152.58271.5e · Cited by 160
Becker, M., Nitsche, A., Neumann, C. M., Aumann, J., Junghahn, I., & Fichtner, I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600573 · Cited by 114
Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters
Schuller, H. M., Porter, B., & Riechert, A. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/pl00008474 · Cited by 106
Neurotransmitters regulate the migration and cytotoxicity in natural killer cells
Lang, K., Drell, T. L., Niggemann, B., Zänker, K. S., & Entschladen, F. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.09.004 · Cited by 84
Self-citationNeurotransmitters are regulators for the migration of tumor cells and leukocytes
Entschladen, F., Lang, K., Drell, T. L., Joseph, J., & Zaenker, K. S. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0300-8 · Cited by 82
Self-citationFelten, D. L. (2008) · Neuropsychobiology · doi:10.1159/000119011 · Cited by 71
Les traitements par β-bloquants pourraient-ils être associés à une diminution du risque de cancer ?
Algazi, M., Plu‐Bureau, G., Flahault, A., Dondon, M., & Lê, M. G. (2004) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/s0398-7620(04)99022-0 · Cited by 68
Heffner, K. L., Loving, T. J., Robles, T. F., & Kiecolt-Glaser, J. K. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00076-4 · Cited by 61
Cited by
Autonomic nerve development contributes to prostate cancer progression
Magnon, C., Hall, S. J., Lin, J., Xue, X., Gerber, L., Freedland, S. J., & Frenette, P. S. (2013) · Science · doi:10.1126/science.1236361 · Cited by 1,287
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Cole, S. W., & Sood, A. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0641 · Cited by 681
Sympathetic nervous system regulation of the tumour microenvironment
Cole, S. W., Nagaraja, A. S., Lutgendorf, S. K., Green, P. A., & Sood, A. K. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3978 · Cited by 576
Beta Blockers and Breast Cancer Mortality: A Population- Based Study
Barron, T. I., Connolly, R. M., Sharp, L., Bennett, K., & Visvanathan, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5422 · Cited by 529
Powe, D. G., Voss, M. J., Zänker, K. S., Habashy, H. O., Green, A. R., Ellis, I. O., & Entschladen, F. (2010) · Oncotarget · doi:10.18632/oncotarget.197 · Cited by 453
Self-citation
Metadata
- Authors
- Palm, D., Lang, K., Niggemann, B., Drell, T. L., Masur, K., Zaenker, K. S., & Entschladen, F.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-03-14
- Volume
- 118
- Issue
- 11
- Pages
- 2744-2749
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2020961525
- Cited by
- 298
- References
- 21
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.